跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
氨己烯酸口服溶液用散 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Vigabatrin Powder for Oral Solution
Approved
化学药品
Vigabatrin Powder for Oral Solution
Aucta Pharmaceuticals, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Jun 25, 2021
Approval ID
887Aa1rdDNY
Company
Aucta Pharmaceuticals, Inc.
Type
化学药品
Approval Details
Approval Id
887Aa1rdDNY
Approval Number
国药准字HJ20210049
Generic Name
氨己烯酸口服溶液用散
Generic Name En
Vigabatrin Powder for Oral Solution
Drug Type
化学药品
Dosage Form
散剂
Strength
500mg
Reg Date
2021-06-25
Expired Date
2026-06-24
Company Name
Aucta Pharmaceuticals, Inc.
Production Company Name
Catalent Germany Schorndorf GmbH
Company Detail Path
/organization/aucta-pharmaceuticals-inc
Production Company Detail Path
/organization/catalent-germany-schorndorf-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 25, 2021
Approval ID
887Aa1rdDNY
Type
化学药品
Back to NMPA Approvals